All news from Anaesthesiology

RNAscope ISH Technology: Bio-Techne Expands Automation Capabilities

Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays. The developments increase both access to, and use of, RNAscope and improve overall robustness and ease-of-use.

The continued investment in automation builds on successful agreements with equipment providers and is driven by Bio-Techne’s desire to facilitate drug discovery and development via rapid, easy, and accurate gene expression detection and localization.

Hypofibrinogenemia in Acute Trauma Patients and The Factors Affecting

Timely and aggressive hemostatic therapy is known as two major measures for improving the patients' survival. Considering the important role of fibrinogen depletion in the occurrence of acute traumatic coagulopathy, timely replacement of this blood product can affect trauma patients' outcome. Nevertheless, presently there are ongoing discussions about the time to start, the amount, and the ratio of blood products transfusion (particularly fibrinogen) in trauma patients.